International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(1), С. 426 - 426
Опубликована: Янв. 6, 2025
Melanoma
is
among
the
most
common
malignancies
and
has
recently
exhibited
increased
resistance
to
treatments,
resulting
in
a
more
aggressive
disease
course.
Mesenchymal
stem
cells
(MSCs)
secrete
cytokines
both
vivo
vitro,
which
regulate
tumor
cell
signaling
pathways
microenvironment,
thereby
influencing
progression.
This
study
investigates
anti-melanogenesis
effects
of
sheep
umbilical
cord
mesenchymal
(SUCMSCs)
assess
their
potential
application
melanoma
treatment.
Our
findings
indicate
that,
SUCMSCs
reduce
melanin
content
tyrosinase
activity,
inhibit
viability,
proliferation,
migration,
invasion,
promote
apoptosis.
Subsequent
experiments
confirmed
that
effectively
suppress
growth,
histological
analysis
via
HE
staining
revealed
notable
differences.
Additionally,
transcriptome
sequencing
indicated
anti-tumor
were
primarily
mediated
through
autophagy,
apoptosis,
TGF-β
NF-κB
pathways.
The
RT-qPCR
validation
results
aligned
with
data.
In
summary,
exert
interaction
multiple
cytokines,
demonstrating
significant
for
Cancer Letters,
Год журнала:
2024,
Номер
591, С. 216894 - 216894
Опубликована: Апрель 16, 2024
This
comprehensive
review
delves
into
the
pivotal
role
of
tumor
microenvironment
(TME)
in
cancer
metastasis
and
therapeutic
response,
offering
fresh
insights
intricate
interplay
between
cells
their
surrounding
milieu.
The
TME,
a
dynamic
ecosystem
comprising
diverse
cellular
acellular
elements,
not
only
fosters
progression
but
also
profoundly
affects
efficacy
conventional
emerging
therapies.
Through
nuanced
exploration,
this
illuminates
multifaceted
nature
elucidating
its
capacity
to
engender
drug
resistance
via
mechanisms
such
as
hypoxia,
immune
evasion,
establishment
physical
barriers
delivery.
Moreover,
it
investigates
innovative
approaches
aimed
at
targeting
including
stromal
reprogramming,
modulation,
extracellular
matrix
(ECM)-targeting
agents,
personalized
medicine
strategies,
highlighting
potential
augment
treatment
outcomes.
Furthermore,
critically
evaluates
challenges
posed
by
complexity
heterogeneity
which
contribute
variable
responses
potentially
unintended
consequences.
underscores
need
identify
robust
biomarkers
advance
predictive
models
anticipate
outcomes,
well
advocate
for
combination
therapies
that
address
multiple
facets
TME.
Finally,
emphasizes
necessity
an
interdisciplinary
approach
integration
cutting-edge
technologies
unravel
intricacies
thereby
facilitating
development
more
effective,
adaptable,
treatments.
By
providing
critical
current
state
TME
research
implications
future
oncology,
highlights
evolving
landscape
field.
iScience,
Год журнала:
2024,
Номер
27(6), С. 109979 - 109979
Опубликована: Май 15, 2024
This
review
explores
the
hallmarks
of
cancer
resistance,
including
drug
efflux
mediated
by
ATP-binding
cassette
(ABC)
transporters,
metabolic
reprogramming
characterized
Warburg
effect,
and
dynamic
interplay
between
cells
mitochondria.
The
role
stem
(CSCs)
in
treatment
resistance
regulatory
influence
non-coding
RNAs,
such
as
long
RNAs
(lncRNAs),
microRNAs
(miRNAs),
circular
(circRNAs),
are
studied.
chapter
emphasizes
future
directions,
encompassing
advancements
immunotherapy,
strategies
to
counter
adaptive
integration
artificial
intelligence
for
predictive
modeling,
identification
biomarkers
personalized
treatment.
comprehensive
exploration
these
provides
a
foundation
innovative
therapeutic
approaches,
aiming
navigate
complex
landscape
enhance
patient
outcomes.
Journal of Biomedical Science,
Год журнала:
2025,
Номер
32(1)
Опубликована: Янв. 9, 2025
Abstract
Research
into
cancer
treatment
has
been
mainly
focused
on
developing
therapies
to
directly
target
cells.
Over
the
past
decade,
extensive
studies
have
revealed
critical
roles
of
tumour
microenvironment
(TME)
in
initiation,
progression,
and
drug
resistance.
Notably,
cancer-associated
fibroblasts
(CAFs)
emerged
as
one
primary
contributors
shaping
TME,
creating
a
favourable
environment
for
development.
Many
preclinical
identified
promising
targets
CAFs,
demonstrating
remarkable
efficacy
some
CAF-targeted
treatments
models.
Encouraged
by
these
compelling
findings,
therapeutic
strategies
now
advanced
clinical
evaluation.
We
aim
provide
comprehensive
review
relevant
subjects
including
CAF-related
markers
targets,
their
multifaceted
roles,
current
landscape
ongoing
trials.
This
knowledge
can
guide
future
research
CAFs
advocate
investigations
targeting
CAFs.
Molecular Oncology,
Год журнала:
2024,
Номер
18(7), С. 1719 - 1738
Опубликована: Янв. 12, 2024
Metformin
and
IACS‐010759
are
two
distinct
antimetabolic
agents.
Metformin,
an
established
antidiabetic
drug,
mildly
inhibits
mitochondrial
complex
I,
while
is
a
new
potent
I
inhibitor.
Mitochondria
pivotal
in
the
energy
metabolism
of
cells
by
providing
adenosine
triphosphate
through
oxidative
phosphorylation
(OXPHOS).
Hence,
OXPHOS
become
vulnerability
when
targeted
cancer
cells.
Both
drugs
have
promising
antitumoral
effects
diverse
cancers,
supported
preclinical
vitro
vivo
studies.
We
present
evidence
their
direct
impact
on
immunomodulatory
effects.
In
clinical
studies,
observational
epidemiologic
studies
metformin
were
encouraging,
actual
trial
results
not
as
expected.
However,
IACS‐01075
exhibited
major
adverse
effects,
thereby
causing
metabolic
shift
to
glycolysis
elevated
lactic
acid
concentrations.
Therefore,
future
outlook
for
these
depends
preventive
trials
investigations
into
plausible
toxic
normal
IACS‐01075.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Апрель 5, 2024
Cancer
immunotherapy
has
made
tremendous
advancements
in
treating
various
malignancies.
The
biggest
hurdle
to
successful
would
be
the
immunosuppressive
tumor
microenvironment
(TME)
and
low
immunogenicity
of
cancer
cells.
To
make
successful,
‘cold’
TME
must
converted
‘hot’
immunostimulatory
status
activate
residual
host
immune
responses.
this
end,
equilibrium
should
broken,
immunogenic
cell
death
ought
induced
stimulate
tumor-killing
cells
appropriately.
Photodynamic
therapy
(PDT)
is
an
efficient
way
inducing
(ICD)
disrupting
immune-restrictive
tissues.
PDT
trigger
a
chain
reaction
that
have
ICD-induced
antigens
presented
In
principle,
strategic
combination
synergize
enhance
therapeutic
outcomes
many
intractable
tumors.
Novel
technologies
employing
nanocarriers
were
developed
deliver
photosensitizers
immunotherapeutic
efficiently.
New-generation
nanomedicines
been
for
recent
years,
which
will
accelerate
clinical
applications.
International Journal of Molecular Sciences,
Год журнала:
2025,
Номер
26(1), С. 415 - 415
Опубликована: Янв. 6, 2025
Cancer
is
a
complex
genetic
disorder
characterized
by
abnormalities
in
both
coding
and
regulatory
non-coding
RNAs.
microRNAs
(miRNAs)
are
key
RNAs
that
modulate
cancer
development,
functioning
as
tumor
suppressors
oncogenes.
miRNAs
play
critical
roles
progression,
influencing
processes
such
initiation,
promotion,
metastasis.
They
exert
their
effects
targeting
suppressor
genes,
thereby
facilitating
while
also
inhibiting
oncogenes
to
prevent
further
disease
advancement.
The
miR-10
family,
particularly
miR-10a-5p
miR-10b-5p
(miR-10a/b-5p),
notably
involved
progression.
Intriguingly,
functions
can
differ
across
different
cancers,
sometimes
promoting
at
other
times
suppressing
growth
depending
on
the
type
target
genes.
This
review
explores
dual
of
miR-10a/b-5p
tumor-suppressive
(TSmiRs)
or
oncogenic
(oncomiRs)
various
cancers
examining
molecular
cellular
mechanisms
impact
microenvironment.
Furthermore,
we
discuss
potential
therapeutic
targets,
emphasizing
miRNA-based
strategies
for
treatment.
insights
discussed
this
aim
advance
our
understanding
miR-10a/b-5p’s
biology
application
developing
innovative
therapies.
Frontiers in Oncology,
Год журнала:
2025,
Номер
14
Опубликована: Янв. 6, 2025
Cancer
is
caused
by
complex
interactions
between
genetic,
environmental,
and
lifestyle
factors,
making
prevention
strategies,
including
exercise,
a
promising
avenue
for
intervention.
Physical
activity
associated
with
reduced
cancer
incidence
progression
systemic
anti-cancer
effects,
improved
tumor
suppression
prolonged
survival
in
preclinical
models.
Exercise
impacts
the
body's
nutrient
balance
stimulates
release
of
several
exercise-induced
factors
into
circulation.
The
mechanisms
how
exercise
modulates
energy
metabolism
microenvironment
through
effects
mediated,
part,
extracellular
vesicles
(EVs)
are
still
unknown.
By
transferring
bioactive
cargo
such
as
miRNAs,
proteins
metabolites,
EVs
may
influence
cells
altering
glycolysis
oxidative
phosphorylation,
potentially
shifting
metabolic
plasticity
-
hallmark
cancer.
This
short
review
explores
roles
mediators
to
reprogram
cellular
exchanging
information
inside
microenvironment,
influencing
immune
cells,
fibroblast
distant
cells.
Considering
this
knowledge,
further
functional
studies
production
pathways
could
inform
more
specific
interventions
enhance
therapy
improve
patient
outcomes.
Regeneration
is
the
replacement
of
lost
or
damaged
tissue
with
a
functional
copy.
In
axolotls
and
zebrafish,
regeneration
involves
stem
cells
produced
by
de-differentiation.
These
form
growth
zone
which
expresses
developmental
patterning
genes
at
its
apex.
This
system
resembles
an
embryonic
field
where
undergo
pattern
formation.
Some
lizards,
including
geckos,
can
regenerate
their
tails,
but
it
unclear
whether
they
show
"development-like"
pathway.
Using
tokay
gecko
(Gekko
gecko)
model
species,
we
examined
seven
stages
tail
regeneration,
three
bud
development,
using
transcriptomics,
single-cell
sequencing,
in
situ
hybridization.
We
find
no
apical
regenerating
tail.
The
transcriptomes
vs.
tails
are
quite
different
respect
to
genes.
Posterior
HOXC
were
activated
temporally
collinear
sequence
major
precursor
populations
stromal
(regenerating
tail)
pluripotent
(embryonic
tail).
Segmented
skeletal
muscles
regenerated
expression
classical
segmentation
genes,
early
activation
satellite
cell
markers.
Our
study
suggests
that
gecko—unlike
development—might
rely
on
resident
cells,
guided
pre-existing
positional
information.